Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine

BMC Infectious Diseases

Table 8 The outcome of patients in relation to certain risk factors

Risk factor	Number of patients survived (%)	Number of dead patients (%)	p value
Comorbidities¹	42 (77.8)	12 (22.2)	0.053*
Cancer with metastasis	28 (70)	12 (30)	0.970*
Recent chemotherapy use²	53 (70.7)	22 (29.3)	0.569*
Recent radiotherapy use*	6 (50)	6 (50)	0.067*
Shock at presentation	13 (52)	12 (48)	0.010*
Recent corticosteroid use²	10 (58.8)	7 (41.2)	0.175*
Recent use of immunosuppressive medication use²	4 (66.7)	2 (33.3)	0.667^f
Previous antibiotic use²	47 (70.1)	20 (29.9)	0.523*
Previous invasive procedures³	44 (71)	18 (29)	0.709*

¹Comorbidities such as diabetes mellitus, hypertension, chronic kidney disease, inflammatory bowel disease, cardiac diseases, thyroid disorders, pulmonary diseases, and neurological disorders
²During a month before the occurrence of the blood stream infection
During the ten days preceding the bloodstream infection
*Using the chi-square test
^fusing Fisher’s exact test
The italic p-value denotes statistical significance

ISSN: 1471-2334